Furthermore, platelet membrane helped tPA-Ald-PM-NP@BTZ achieve secondary targeting from bone microenvironment to myeloma cells by specific affinity between P-Selectin on PM and CD44 receptor on myeloma cells. The gene discussed is SELP; the disease is plasma cell myeloma.